The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
This one-of-a-kind innovation challenge is aimed at addressing the challenges faced by healthcare providers in digital technology adoption
Crosscope and KFBIO join forces to lead digital transformation for pathology in India and emerging markets
Implementation of the system to provide faster, seamless and hassle-free healthcare solutions
The hospital chain aggressively embarks on digitisation and is e-health ready
The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.
In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline
Subscribe To Our Newsletter & Stay Updated
